Conversely, the overexpression of PGC-1α in skeletal muscle cells has been shown to increase frataxin levels [65], and the PPAR-γ agonist Azelaoyl PAF is able to increase FXN gene expression and frataxin protein levels in FRDA cells [66]. The gene discussed is FXN; the disease is Friedreich ataxia.